文献速递血液净化与透析水电解质与酸碱

中毒与药物过量的管理

Management of Poisonings and Intoxications.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-01-13

综述肾内科医生参与中毒患者管理的整体方法,包括初始复苏、风险评估、胃肠道去污、解毒剂及体外清除技术。体外清除适用于低分子量、水溶性、蛋白结合率低(<80%)且内源性清除率和分布容积低的药物,间歇性血液透析为多数情况下的推荐方式。

要点

  • 中毒患者管理包括初始急性复苏、风险评估及必要时限时干预如活性炭和解毒剂。
  • 体外清除需考虑严重毒性存在或预计持续,以及毒物能否被显著清除。
  • 间歇性血液透析是多数需体外治疗病例的推荐方式,因其最为高效。

核心结论

  • 肾内科医生参与中毒管理主要涉及体外清除技术的应用,需评估临床指征和毒物特性以决定是否及如何实施体外治疗。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 体外清除对低分子量、水溶性、蛋白结合率<80%、内源性清除率和分布容积低的药物最大化。
  • 启动体外治疗后,某些解毒剂(如N-乙酰半胱氨酸、乙醇、甲吡唑)的剂量应增加以维持治疗浓度。
  • 为最大化体外清除效果,应优化血液和废液流速,选择最大表面积的滤器,并个体化调整持续时间以清除足够毒物。

关键数值与推荐

  • 体外清除的临床指征包括存在严重毒性、预计出现严重毒性或毒性将持续,以及毒物能被体外治疗显著清除。
  • 间歇性血液透析在多数需要体外治疗的情况下被推荐,因其最为高效;连续性肾脏替代治疗在特定情况下使用,尤其当间歇性血液透析不易获得时。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Poisoning occurs after exposure to any of a number of substances, including medicines, which can result in severe toxicity including death. The nephrologist may be involved in poisonings that cause kidney disease and for targeted treatments. The overall approach to the poisoned patient involves the initial acute resuscitation and performing a risk assessment, whereby the exposure is considered in terms of the anticipated severity and in the context of the patient's status and treatments that may be required. Time-critical interventions such as gastrointestinal decontamination ( e.g. , activated charcoal) and antidotes are administered when indicated. The nephrologist is usually involved when elimination enhancement techniques are required, such as urine alkalinization or extracorporeal treatments. There is increasing data to guide decision making for the use of extracorporeal treatments in the poisoned patient. Principles to consider are clinical indications such as whether severe toxicity is present, anticipated, and/or will persist and whether the poison will be significantly removed by the extracorporeal treatment. Extracorporeal clearance is maximized for low-molecular weight drugs that are water soluble with minimal protein binding (<80%) and low endogenous clearance and volume of distribution. The dosage of some antidotes ( e.g. , N-acetylcysteine, ethanol, fomepizole) should be increased to maintain therapeutic concentrations once the extracorporeal treatment is initiated. To maximize the effect of an extracorporeal treatment, blood and effluent flows should be optimized, the filter with the largest surface area selected, and duration tailored to remove enough poison to reduce toxicity. Intermittent hemodialysis is recommended in most cases when an extracorporeal treatment is required because it is the most efficient, and continuous kidney replacement therapy is prescribed in some circumstances, particularly if intermittent hemodialysis is not readily available.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ghannoum M, Roberts DM. Management of Poisonings and Intoxications. Clin J Am Soc Nephrol. 2023. PMID: 37097121. doi:10.2215/CJN.0000000000000057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。